Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (13 ops.)
Latest filing published 28 Sept 2026 for Corcept Therapeutics INC. Read the official filing
Filing timeline
BuySaleGary Charles Robb
Insider track record
Disclosed buys
0
Disclosed sells
13
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Gary Charles Robb: trading record in brief
Gary Charles Robb, listed as senior executive, appears in our data through filings on Corcept Therapeutics Inc shares, published by SEC (Form 4). We count 68 filings; the first trade dates from 30 August 2021 and the latest from 24 September 2026.
No open-market purchase appears, only 13 sales worth €4.9M. Besides market trades, the filings include 20 share grants and 13 option exercises. Since January 2026: no purchases and 1 sale on the market.
On 28 September 2026 came the latest disclosure, a transaction in Corcept Therapeutics Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Gary Charles Robb
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations68 total
17,100 shares0Common StockSEC:0001193125-26-405402:0
5,000 shares0Common StockSEC:0001193125-26-405402:1
5,000 shares0Common StockSEC:0001193125-26-405402:2
17,493 shares@ US$8.270.0011% mcap2.1% of flowCommon StockSEC:0001193125-26-395827:0
164 shares0Common StockSEC:0001193125-26-382457:1
164 shares@ US$113.380.0001% mcap0.3% of flowCommon StockSEC:0001193125-26-382457:0
91 shares@ US$113.380.0001% mcap0.1% of flowCommon StockSEC:0001193125-26-382457:2
125 shares0Common StockSEC:0001193125-26-355560:0
10,000 shares@ US$116.25720.0092% mcap50.0% of flowCommon StockSEC:0001193125-26-355560:1
3,000 shares0Common StockSEC:0001193125-26-352428:1
11,530 shares0Common StockSEC:0001193125-26-352428:0
3,000 shares0Common StockSEC:0001193125-26-352428:2
600 shares0Common StockSEC:0001193125-26-298871:0
776 shares0Common StockSEC:0001193125-26-256002:1
776 shares@ US$70.440.8% of flowCommon StockSEC:0001193125-26-256002:0
358 shares@ US$70.440.4% of flowCommon StockSEC:0001193125-26-256002:2
1,000 shares0Common StockSEC:0001193125-26-227411:1
1,000 shares0Common StockSEC:0001193125-26-227411:2
5,300 shares0Common StockSEC:0001193125-26-227411:0
499 shares@ US$35.970.3% of flowCommon StockSEC:0001193125-26-092158:0
145,000 shares@ US$3.888.0% of flowCommon StockSEC:0001193125-25-335575:0
224 shares@ US$79.780.3% of flowCommon StockSEC:0001193125-25-307213:0
251 shares@ US$71.380.3% of flowCommon StockSEC:0001193125-25-196309:0
5,000 shares@ US$3.880.3% of flowCommon StockSEC:0001193125-25-188869:0
3,185 shares@ US$70.773.3% of flowCommon StockSEC:0000950170-25-088005:0
25 of 68 declarations
